Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study

The recent decades have ushered in considerable advancements in the diagnosis and treatment of systemic light chain (AL) amyloidosis. As disease outcomes improve, AL amyloidosis-unrelated factors may impact mortality. In this study, we evaluated survival trends and primary causes of death among 2337...

Descripción completa

Detalles Bibliográficos
Autores principales: Staron, Andrew, Zheng, Luke, Doros, Gheorghe, Connors, Lawreen H., Mendelson, Lisa M., Joshi, Tracy, Sanchorawala, Vaishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338947/
https://www.ncbi.nlm.nih.gov/pubmed/34349108
http://dx.doi.org/10.1038/s41408-021-00529-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338947/
https://www.ncbi.nlm.nih.gov/pubmed/34349108
http://dx.doi.org/10.1038/s41408-021-00529-w

Ejemplares similares